A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome

doi:10.3748/wjg.v16.i5.547

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9874)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-5) series.

Item

Count

PDF

961

HTML

8331

Figures (1-4)

297

Tables (1-5)

285

Sum=9874

Feb 7, 2010 (publication date) through Dec 20, 2024

Times Cited of This Article

Times Cited (49)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Feb 7, 2010; 16(5): 547-553
Published online Feb 7, 2010. doi: 10.3748/wjg.v16.i5.547

Full Size Figure Download Figure

Figure 2 Individual and pooled relative risk (A), heterogeneity indicators (B), and publication bias indicators (C) for the outcome of “global or clinical improvement” in the studies comparing mebeverine vs placebo therapy.

Citation: Darvish-Damavandi M, Nikfar S, Abdollahi M. A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome. World J Gastroenterol 2010; 16(5): 547-553
URL: https://www.wjgnet.com/1007-9327/full/v16/i5/547.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i5.547